Protein biopolymer markers predictive of insulin resistance

Details Protein biopolymer markers predictive of insulin resistance Protein biopolymer markers predictive of insulin resistance

2006-05-30

2006-05-30

Le, Long V. (Department: 1641)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007200, C435S007210, C436S063000, C436S086000, C436S173000, C436S518000, C530S350000

Reexamination Certificate

active

07052849

ABSTRACT:
The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

REFERENCES:
patent: 5062935 (1991-11-01), Schlag et al.
patent: 5744368 (1998-04-01), Goldgaber et al.
patent: 6020208 (2000-02-01), Hutchens et al.
patent: 0 267 703 (1988-05-01), None
patent: WO 90/14148 (1990-11-01), None
patent: WO 93/24834 (1993-12-01), None
patent: WO 98/07036 (1998-02-01), None
patent: WO99/42829 (1999-08-01), None
patent: WO 01/13117 (2001-02-01), None
patent: WO01/38395 (2001-05-01), None
patent: WO 01/62785 (2001-08-01), None
patent: WO01/63294 (2001-08-01), None
patent: WO 01/69261 (2001-09-01), None
patent: WO01/75454 (2001-10-01), None
patent: WO02/24887 (2002-03-01), None
patent: WO02/059621 (2002-08-01), None
Tascilar et al. (Annals of Oncology 10,Supp1.4:S107-S1 10, 1999).
Tockman (Cancer Research 52:2711s-2718s, 1992).
Zhang et al. Neurobiology of Aging, vol. 26, p. 207 (2005).
M. Valle et al, “APO-AI Decrease and Triglycerides Increase Serum Levels in Hiperinsulinemic Obese Children”, Clinical Chemistry and Laboratory Medicine, 39:S247 XP009008523 (May 2001) (Abstract).
K. Murao et al, “Effects of Glucose and Insulin on Rat Apolipoprotein A-I Gene Expression”, J. Biol. Chem., 273(30):18959-18965 (Jul., 1998).
K. Moskowitz et al, “Fibrinogen Coating Density Affects the Conformation of Immobilized Fibrinogen: Implications for Platelet Adhesion and Spreading”, Thrombosis and Haemostasis, 79(4):824-831 (Apr., 1998).
P. Grant, “Polymorphisms of Coagulation/Fibrinolysis Genes: Gene Environment Interactions and Vascular Risk”, Prostaglandins Leukotrienes and Essential Fatty Acids, 57(4-5):473-477 (Oct., 1997).
G. Imperatore et al, “Plasma Fibrinogen: A New Factor of the Metabolic Syndrome”, Diabetes Care, 21(4):649-654 (Apr., 1998).
Takahashi et al., “Rapid and Sensitive Immunoassay for the Measurement of Serum S100β Using Isoform-specific Monoclonal Antibody”, Clinical Chemistry 45, No. 8, (1999) pp. 1307-1311.
Richter et al., “Composition of the peptide fraction in human blood plasma: database of circulating human peptides”, Journal of Chromatography B; 726 (1999) pp. 25-35.

Affiliated with

Also associated with

Rating

Protein biopolymer markers predictive of insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein biopolymer markers predictive of insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein biopolymer markers predictive of insulin resistance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3582197